Share >  
Share
Share on Tumblr

Glenmark Generics Limited

News »

   latest by relevance
Glenmark gets tentative US nod for migraine treatment drug
May 16, 2012 at 12:24 | Source: Moneycontrol.com
Glenmark Pharma's US generics arm has received tentative approval from US Food and Drugs Administration (FDA) for Zolmitriptan orally disintegrating tablets, its copy of AstraZeneca's ZomigZMT tablets.
Glenmark sees 22-25% sales growth, no acquisitions in FY13
May 09, 2012 at 12:08 | Source: Moneycontrol.com
After a strong growth in 2011-12, Glenmark Pharmaceuticals expects to continue strong growth momentum this year too. It expects sales will rise 22-25% (excluding licensing income), helped by new drug launches in the US market and strong growth in most other regions.
Launches in FY13 to boost growth in Indian market: Glenmark
May 09, 2012 at 11:42 | Source: CNBC-TV18
Aided by malarone and cutivate generic, the US business of Glenmark Pharma saw recovery in the fourth quarter of FY12. In an interview with CNBC-TV18, Glenn Saldanha, MD & CEO of Glenmark said, the company expects its domestic market to outperform industry in FY13.
Glenmark gets US FDA nod for generic antiepileptic drug
May 07, 2012 at 14:27 | Source: Moneycontrol.com
Glenmark Phama's arm Glenmark Generics USA has received US Food and Drugs Administration Approval for its abbreviated new drug approval (ANDA) for Lamotrigine Tablets in various strengths.
Glenmark gets US nod for another oral contraceptive generic
Apr 09, 2012 at 11:21 | Source: Moneycontrol.com
Glenmark Pharma's US Generics arm has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) for oral contraceptive Norgestimate and Ethinyl Estradiol tablets 0.25/0.035 mg strength.
Glenmark gets US nod for oral contraceptive Mircette copy
Apr 03, 2012 at 11:22 | Source: Moneycontrol.com
Drug maker Glenmark Pharmaceuticals' US generics arm has received final approval from US Food and Drugs Administration to sell Desogestrel and Ethinyl Estradiol tablets of 0.15 mg/0.02 mg strengths.

Videos »
Launches in FY13 to boost growth in Indian market: Glenmark
Profit down 35%, but topline at record Rs 1055 cr: Glenmark
Glenmark settles patent litigation with Daiichi, Genzyme
Glenmark confident of US growth despite Tarka issue
No plans to list generics biz as of now: Glenmark
more »

Photos »

  /  
News across the web »
US recalls Glenmark’s India made birth control pills
New York: Glenmark Generics has recalled its version of oral birth control pills manufactured in India for the US market due to a packaging error that landed the pills in the wrong order and could ma...
Feb 28, 2012 at 08:31 | Source: FirstPost
Micromax, Pride Hotels among IPOs expired in Jan 2012
PUNE: Initial public offers or IPOs amounting to Rs 30,000 expired in 2011, on low interest of investors. While the markets have started to pick up in calendar 2012, it is yet to be attractive for th...
Jan 27, 2012 at 22:22 | Source: Economic Times
more »
Related News »
Glenmark's different route to US drug market
At a time when most Indian drug makers are launching generics to monetise patent expiries in the US, Glenmark has chosen to walk a road less travelled. The company has chosen a strategy to capture niche segments with limited competition, such as ...
May 20, 2012 at 19:01 | Source: Business Standard
Search Results glenn saldanha
The company has chosen a strategy to capture niche segments with limited competition ... reforms may turnout to be a booster for Indian companies operating in generics space. Glenmark Pharmaceuticals' molecule, GRC 4039, for treating rheumatoid arthritis ...
May 24, 2012 at 19:32 | Source: Business Standard
Glenmark Generics receives tentative U.S. FDA approval for zolmitriptan orally disintegrating tablets
Glenmark Generics Inc. USA the United States subsidiary of Glenmark Generic Limited, announced today that the United States Food and Drug Administration (U.S. FDA) has granted tentative approval for zolmitriptan orally disintegrating tablets ...
May 16, 2012 at 07:17 | Source: equitybulls.com
For drugmakers, prices falling in the US
Indian drugmakers such as Glenmark, Lupin, Sun Pharma and Dr Reddy’s that are ... thereby leading to a not-so-steep fall in prices. Unlike other generics where price erosion due to competition could be as high as 80-90%, in complex therapies it is ...
May 25, 2012 at 03:25 | Source: Daily News and Analysis

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window